The effects of combination glaucoma medications on ocular surface epithelial cells

[1] Horsley M.B.(2009)Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients Clin Ophthalmol. 3 291-295

[2] Kahook M.Y.(2004)Corneal and conjunctival changes caused by commonly used glaucoma medications Cornea 23 490-496

[3] Noecker R.J.(2004)Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study Invest Ophthalmol Vis Sci. 45 1360-1368

[4] Herrygers L.A.(2008)Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears Cornea. 27 339-343

[5] Anwaruddin R.(2000)Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells Curr Eye Res. 20 85-94

[6] Pisella P.J.(2007)Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells Kaohsiung J Med Sci. 23 105-111

[7] Debbasch C.(2001)Effects of common ophthalmic preservatives on ocular health Adv Ther. 18 205-215

[8] Hamard P.(2009)Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells J Ocul Pharmacol Ther. 25 113-119

[9] Kahook M.Y.(2006)Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride Adv Ther. 23 663-671

[10] Noecker R.J.(2006)Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system Adv Ther. 23 511-519

[1] Horsley M.B.(2009)Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients Clin Ophthalmol. 3 291-295

[2] Kahook M.Y.(2004)Corneal and conjunctival changes caused by commonly used glaucoma medications Cornea 23 490-496

[3] Noecker R.J.(2004)Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study Invest Ophthalmol Vis Sci. 45 1360-1368

[4] Herrygers L.A.(2008)Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears Cornea. 27 339-343

[5] Anwaruddin R.(2000)Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells Curr Eye Res. 20 85-94

[6] Pisella P.J.(2007)Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells Kaohsiung J Med Sci. 23 105-111

[7] Debbasch C.(2001)Effects of common ophthalmic preservatives on ocular health Adv Ther. 18 205-215

[8] Hamard P.(2009)Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells J Ocul Pharmacol Ther. 25 113-119

[9] Kahook M.Y.(2006)Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride Adv Ther. 23 663-671

[10] Noecker R.J.(2006)Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system Adv Ther. 23 511-519